Related Experiment Video
Updated: May 22, 2026

Investigating Long-Distance Transport of Perfluoroalkyl Acids in Wheat via a Split-Root Exposure Technique
Published on: September 28, 2022
Associations between maternal exposure to per- and polyfluoroalkyl substances and functional constipation in children
Kohei Hasegawa1,2, Yuji Inaba2,3,4, Shoji Saito5
1Department of Preventive Medicine and Public Health, Shinshu University School of Medicine.
Background:
Research over the past decade has indicated that exposure to per- and polyfluoroalkyl substances (PFAS) disrupts the intestinal barrier, potentially contributing to the development of gastrointestinal disorders. More recently, constipation has been hypothesized as one such outcome. However, epidemiological studies examining this association remain limited.
Methods:
We analyzed data from 17,686 mothers and their children from the Japan Environment and Children's Study, a Japanese birth cohort study. We used maternal plasma samples collected during pregnancy to determine PFAS concentrations. Of the 28 PFAS compounds analyzed, we included seven compounds that were quantified in more than 80% of the samples. We assessed functional constipation in children at ages 3 and 4 using caregiver-completed questionnaires based on the Rome III criteria. Logistic regression models were used to examine associations between maternal PFAS concentrations and childhood functional constipation, applying a Bonferroni-corrected significance threshold of P < 0.0035 to account for multiple comparisons.
Results:
Functional constipation was observed in 11.3% of children at age 3 and 9.8% at age 4. After adjusting for potential confounders, we observed no significant associations between any of the seven maternal PFAS concentrations and functional constipation in children at 3 years of age. However, at 4 years, perfluorooctanoic acid (PFOA) concentrations were significantly associated with functional constipation, with an adjusted odds ratio of 1.13 (95% confidence interval: 1.05-1.21, P = 0.00057) per doubling of concentration. The remaining six PFAS compounds showed no significant associations at 4 years.
Conclusions:
The single positive association between maternal PFOA concentration and functional constipation at 4 years of age is unlikely to reflect a true causal relationship, given limited biological plausibility. Our results do not provide evidence of an association between prenatal PFAS exposure and functional constipation in children, although further investigation is warranted.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
